SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $161,000 | -22.2% | 36,093 | -5.0% | 0.07% | -16.5% |
| Q2 2021 | $207,000 | +7.3% | 37,977 | +47.4% | 0.08% | +3.7% |
| Q1 2021 | $193,000 | -29.8% | 25,773 | +1.8% | 0.08% | -28.1% |
| Q4 2020 | $275,000 | -10.7% | 25,323 | -27.3% | 0.11% | -29.6% |
| Q3 2020 | $308,000 | -27.0% | 34,835 | -12.0% | 0.16% | -19.0% |
| Q2 2020 | $422,000 | -0.5% | 39,578 | +11.2% | 0.20% | +354.5% |
| Q3 2018 | $424,000 | -32.7% | 35,601 | -42.3% | 0.04% | -92.1% |
| Q2 2018 | $630,000 | – | 61,719 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |